Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Police say violent crime improving in downtown Raleigh, but more work is needed
Recommended
Cyclospora parasite illnesses have affected 28 NC counties, sickened more than 200 people
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Biora Therapeutics, Inc.
< Previous
1
2
Next >
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Funding Agreement with Existing Investors
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
August 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
July 18, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
July 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
July 01, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
June 11, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
May 20, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 15, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update
May 07, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024
May 06, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
April 30, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
April 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
April 04, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 03, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 01, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
March 26, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
March 18, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset
March 11, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
February 26, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium
February 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.
January 22, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Outlook for 2024
January 16, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600
January 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
January 02, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform
December 19, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors
December 18, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
December 11, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
November 30, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.